- €571.97m
- €1.74bn
- €184.16m
- 32
- 86
- 69
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 241 | 220 | 191 | 163 | 184 |
Cost of Revenue | |||||
Gross Profit | 171 | 133 | 125 | 115 | 126 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 535 | 395 | 380 | 76.8 | 59.7 |
Operating Profit | -294 | -174 | -189 | 85.8 | 124 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -324 | -196 | -215 | 76.1 | 89.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -319 | -194 | -213 | 76 | 89.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -329 | -187 | -226 | 57.3 | 79.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -329 | -187 | -226 | 57.3 | 79.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -8.18 | -4.65 | -2.17 | 1.57 | 1.97 |
Dividends per Share |